AMBER WADE: Open Payments
NPI 1568862001 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 101 payments from 34 companies in 2025. Trend: 2023 $2,623 · 2024 $2,069 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $168 |
| Eisai Inc. | 8 | $165 |
| Merck Sharp & Dohme LLC | 5 | $155 |
| Daiichi Sankyo Inc. | 6 | $151 |
| E.R. Squibb & Sons, L.L.C. | 8 | $145 |
| PFIZER INC. | 8 | $144 |
| Adaptive Biotechnologies Corporation | 4 | $92 |
| ABBVIE INC. | 4 | $84 |
| Gilead Sciences, Inc. | 4 | $81 |
| Incyte Corporation | 4 | $80 |
Products named: Lenvima, KEYTRUDA, ENHERTU, ERLEADA, VENCLEXTA, clonoSEQ, Trodelvy, VERZENIO.
Industry payments across TN — which companies pay providers there.
